Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides oncological medical services. Joint-stock company providing specialized oncological healthcare services.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,709 | 4,471 | 3,380 | 1,096 | 0 | 162 | 68 | 150 | -38.9% |
| Total COGS | 452 | 454 | 316 | 118 | 0 | 0 | 0 | 0 | -36.1% |
| Gross Profit | 4,257 | 4,017 | 3,064 | 978 | 0 | 162 | 68 | 150 | -38.0% |
| Gross Margin | 90.4% | 89.8% | 90.7% | 89.2% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 324 | 3,959 | 3,499 | 1,615 | 0 | 220 | 204 | 153 | -10.2% | |
| EBITDA | 3,933 | 58 | 435 | 637 | 0 | 57 | 136 | 3 | nmf |
| EBITDA Margin | 83.5% | 1.3% | 12.9% | 58.1% | 21.2% | 35.2% | 199.9% | 2.1% | |
| Total D&A | 507 | 509 | 376 | 344 | 0 | 763 | 662 | 795 | +6.6% |
| EBIT / Operating Income | 3,426 | 451 | 811 | 981 | 0 | 820 | 798 | 798 | nmf |
| Profit Before Tax | 3,426 | 451 | 811 | 981 | 0 | 820 | 798 | 798 | nmf |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 232 | 451 | 811 | 981 | 0 | 820 | 798 | 798 | +19.3% |
| Net Margin | 4.9% | 10.1% | 24.0% | 89.5% | 148.2% | 504.6% | 1174.4% | 533.4% | |
| Other Comprehensive Income | 0 | 0 | 0 | 0 | 25 | 0 | 0 | 4,675 | nmf |
| Total Comprehensive Income | 232 | 451 | 811 | 981 | 24 | 820 | 798 | 3,878 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →